Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsHaematology

ICU · Haematology

Disseminated intravascular coagulation: ISTH score, transfusion, and management

Also known as DIC · Disseminated intravascular coagulation · Consumptive coagulopathy · ISTH overt-DIC score

Disseminated intravascular coagulation (DIC) = systemic activation of coagulation - microvascular thrombosis + consumption of platelets/clotting factors - BLEEDING + THROMBOSIS simultaneously. CAUSES: sepsis (most common — 50%), trauma, malignancy (leukaemia, solid tumour — mucin), obstetric (amniotic fluid embolus, placental abruption, severe pre-eclampsia/HELLP), transfusion reaction, snake bite, severe liver disease. CLINICAL: BLEEDING (oozing from IV sites, gums, GI, GU, petechiae, ecchymoses — from consumed platelets/factors) + THROMBOSIS (purpura fulminans, digital ischaemia, AKI, ARDS, MOF — from microvascular clots). DIAGNOSIS: ISTH overt-DIC score (platelets, fibrinogen, FDP/D-dimer, PT — score ≥5 = overt DIC). MANAGEMENT: TREAT THE UNDERLYING CAUSE (the 1 priority — antibiotics for sepsis, delivery for obstetric, etc.) + SUPPORTIVE (transfuse platelets/fresh frozen plasma/cryoprecipitate if bleeding or high risk — NOT prophylactically) ± ANTICOAGULATION (controversial — for thrombotic DIC — heparin). MORTALITY: 40-80% (high — reflects underlying severity).

high13 referencesUpdated 20 Aug 202618 min readVerification in progress

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • DIC = BLEEDING + THROMBOSIS simultaneously (microvascular clots + consumed factors)
  • ISTH overt-DIC score ≥5 = overt DIC (platelets, fibrinogen, D-dimer, PT)
  • TREAT THE UNDERLYING CAUSE is the #1 priority (sepsis, malignancy, obstetric)
  • Transfuse platelets/FFP/cryoprecipitate if BLEEDING or HIGH RISK (not prophylactically)
  • Mortality 40-80% (reflects underlying severity)
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • DIC = BLEEDING + THROMBOSIS simultaneously (microvascular clots + consumed factors)
  • ISTH overt-DIC score ≥5 = overt DIC (platelets, fibrinogen, D-dimer, PT)
  • TREAT THE UNDERLYING CAUSE is the #1 priority (sepsis, malignancy, obstetric)
  • Transfuse platelets/FFP/cryoprecipitate if BLEEDING or HIGH RISK (not prophylactically)
  • Mortality 40-80% (reflects underlying severity)
In one line

DIC is systemic coagulation activation that lays down microvascular thrombi while it consumes platelets and clotting factors, so the same patient bleeds and thromboses at once. Diagnose it with the ISTH overt-DIC score — platelets, fibrinogen, D-dimer and PT, where a score of five or more is overt DIC. The first priority is treat the underlying cause; transfuse platelets, FFP and cryoprecipitate only when the patient is bleeding or at high bleeding risk, never prophylactically; reserve heparin for thrombotic-predominant DIC. Mortality runs 40 to 80 per cent.[1]

Meet the patient

A 54-year-old man reaches the unit shocked and confused, oozing steadily from every line site, with fresh purpura spreading over his flanks and necrotic black patches on his fingertips. The gas shows a lactate of 6, the coagulation screen returns platelets 22, INR 2.6, fibrinogen 0.9 and a D-dimer off the scale, and meningococcal sepsis is brewing underneath it.[5]

The two questions that decide his next hour are the two that decide every DIC stem: what is driving the clotting? — treat it now, because the cause is the cure — and is he bleeding or thrombosing? — that single fork decides whether you transfuse or anticoagulate. Hold those two and the management falls into place.[1]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References13ShowHide
  1. [1]Wada H, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. Journal of thrombosis and haemostasis : JTH, 2013.PMID 23379279
  2. [2]Taylor FB Jr, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thrombosis and haemostasis, 2001.PMID 11816725
  3. [3]Iba T, et al. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. Journal of thrombosis and haemostasis : JTH, 2019.PMID 31410983
  4. [4]Levi M, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. British journal of haematology, 2009.PMID 19222477
  5. [5]Papageorgiou C, et al. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018.PMID 30296833
  6. [6]Vincent JL, et al. Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial. JAMA, 2019.PMID 31104069
  7. [7]Misirlioglu R, et al. PAD Score: A Clinical Prediction Tool for Disseminated Intravascular Coagulation in Placental Abruption. Journal of clinical medicine, 2026.PMID 42123258
  8. [8]Bakhtiari K, et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Critical care medicine, 2004.PMID 15599145
  9. [9]Iba T, et al. Introducing the New Definition and Diagnostic Criteria of Disseminated Intravascular Coagulation Released by the International Society on Thrombosis and Haemostasis in 2025. Seminars in thrombosis and hemostasis, 2026.PMID 40829630
  10. [10]Infante JB Predictors of Early Death in Acute Promyelocytic Leukemia. Medical sciences (Basel, Switzerland), 2025.PMID 41440532
  11. [11]Scully M, et al. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. The New England journal of medicine, 2019.PMID 30625070
  12. [12]Sakai K, et al. Characteristics Behaviors of Coagulation and Fibrinolysis Markers in Acquired Thrombotic Thrombocytopenic Purpura. Journal of intensive care medicine, 2021.PMID 31964209
  13. [13]Rock GA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. The New England journal of medicine, 1991.PMID 2062330

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute transfusion reactions: TRALI, TACO, allergic, haemolytic, and septicHaematologyNextHeparin-induced thrombocytopenia (HIT): 4T score, diagnosis, and non-heparin anticoagulationHaematology